Vantage logo

Onduo takes its time

The Verily subsidiary has the luxury of patient backers. But hungrier rivals could steal a march.

Vantage logo

Bayer’s gene therapy juggling act

Two arm’s-length acquisitions and two licensing deals have given Bayer a cell and gene therapy unit; now to bring it all together.

Vantage logo

Thermo Fisher and the new variant

Pinpointing new forms of the coronavirus could be vital, particularly if it mutates in response to vaccination, the company says.

Vantage logo

Astra aims for “the Trump setting”

Pivotal trials of Astrazeneca's Covid-19 antibody get under way, with hopes that a longer half-life and more convenient dosing will set the project apart.

Vantage logo

Novo adds weight to its obesity goals

Analysts see semaglutide helping Novo Nordisk to beat its sales target in obesity, but the company has bigger ambitions for earlier projects.